Hisha Hiroko, Kohdera Urara, Hirayama Masahiro, Yamada Haruki, Iguchi-Uehira Tomoko, Fan Tian-Xue, Cui Yun-Ze, Yang Guo-Xiang, Li Yongan, Sugiura Kikuya, Inaba Muneo, Kobayashi Yohnosuke, Ikehara Susumu
First Department of Pathology, Kansai Medical University, Moriguchi City, Osaka, Japan.
Stem Cells. 2002;20(4):311-9. doi: 10.1634/stemcells.20-4-311.
Juzen-taiho-to (a Japanese herbal medicine) has been traditionally administered to patients with anemia, neutropenia, or wasting syndrome. We previously attempted to isolate and purify the hemopoiesis-stimulatory components in Juzen-taiho-to extracts using an in vitro hemopoietic stem cell (HSC) assay method in which mouse HSCs can proliferate on a stromal cell line (MS-5). We have found that fatty acids (particularly oleic acid and linolenic acid) actively promote the proliferation of HSCs, and that the effect is mediated by stromal cells, rather than by any direct action on the HSCs. In the present study, we show, using human normal bone marrow cells (BMCs) and umbilical cord blood cells, that similar stimulatory effects are due to the presence of oleic acid and linolenic acid, which stimulate the proliferation of HSCs in stroma-based culture systems. Furthermore, a marked stimulatory effect was noted on BMCs from patients with Shwachman syndrome, which shows pancreatic and bone marrow dysfunctions. We also show the data on hemopoietic recovery after the administration of Juzen-taiho-to to a patient with Shwachman syndrome. These findings suggest that decreased fatty acid levels in the blood, caused by exocrine pancreatic insufficiency, induce bone marrow dysfunction in Shwachman syndrome.
十全大补汤(一种日本草药)传统上用于治疗贫血、中性粒细胞减少症或消瘦综合征患者。我们之前尝试使用体外造血干细胞(HSC)检测方法分离和纯化十全大补汤提取物中的造血刺激成分,在该方法中,小鼠造血干细胞可在基质细胞系(MS-5)上增殖。我们发现脂肪酸(特别是油酸和亚麻酸)能积极促进造血干细胞的增殖,且这种作用是由基质细胞介导的,而非对造血干细胞的任何直接作用。在本研究中,我们使用人类正常骨髓细胞(BMC)和脐带血细胞表明,类似的刺激作用归因于油酸和亚麻酸的存在,它们在基于基质的培养系统中刺激造血干细胞的增殖。此外,对于患有施瓦茨曼综合征(表现为胰腺和骨髓功能障碍)的患者的骨髓细胞,观察到了显著的刺激作用。我们还展示了给一名施瓦茨曼综合征患者服用十全大补汤后造血恢复的数据。这些发现表明,外分泌性胰腺功能不全导致血液中脂肪酸水平降低,进而引发施瓦茨曼综合征中的骨髓功能障碍。